Digital Health Initiatives in Rare Disease Management: A Roadmap for India's Orphan Drug Ecosystem

India faces significant challenges in managing rare diseases and providing access to orphan drugs.This study explores the potential of digital health initiatives to transform rare disease management and orphan drug development in India.We analyze the current landscape of digital health in India, focusing on its application to rare diseases.Through a comprehensive review of global best practices and India's unique healthcare context, we propose a roadmap for integrating digital health solutions into India's orphan drug ecosystem.Our findings suggest that telemedicine, Artificial Intelligence (AI)-powered diagnostics, digital patient registries, and mobile health applications can significantly improve rare disease diagnosis, treatment, and research in India.However, challenges such as digital literacy, data privacy, and infrastructure limitations need to be addressed.We conclude that a strategic implementation of digital health initiatives, tailored to India's healthcare landscape, can substantially enhance rare disease management and accelerate orphan drug development.

Publication Details

Journal
TEXILA ADVANCED JOURNAL OF MULTIDISCIPLINARY HEALTH RESEARCH
Published
2025-05-29
DOI
https://doi.org/10.21522/tajmhr.2016.05.01.art005
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Digital Health Initiatives in Rare Disease Management: A Roadmap for India's Orphan Drug Ecosystem

TEXILA ADVANCED JOURNAL OF MULTIDISCIPLINARY HEALTH RESEARCH
Biotechnology and Related Fields
article

Digital Health Initiatives in Rare Disease Management: A Roadmap for India's Orphan Drug Ecosystem

article en

Abstract

India faces significant challenges in managing rare diseases and providing access to orphan drugs.This study explores the potential of digital health initiatives to transform rare disease management and orphan drug development in India.We analyze the current landscape of digital health in India, focusing on its application to rare diseases.Through a comprehensive review of global best practices and India's unique healthcare context, we propose a roadmap for integrating digital health solutions into India's orphan drug ecosystem.Our findings suggest that telemedicine, Artificial Intelligence (AI)-powered diagnostics, digital patient registries, and mobile health applications can significantly improve rare disease diagnosis, treatment, and research in India.However, challenges such as digital literacy, data privacy, and infrastructure limitations need to be addressed.We conclude that a strategic implementation of digital health initiatives, tailored to India's healthcare landscape, can substantially enhance rare disease management and accelerate orphan drug development.

TEXILA ADVANCED JOURNAL OF MULTIDISCIPLINARY HEALTH RESEARCHVol. 5(1)
Zero hunger
Openalex Percentile: Top 83%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Digital Health Initiatives in Rare Disease Management: A Roadmap for India's Orphan Drug Ecosystem · TEXILA ADVANCED JOURNAL OF MULTIDISCIPLINARY HEALTH RESEARCH (2025) | TGRS Research Map | TGRS